
|Videos|May 24, 2017
The Therapeutic Approach for Malignant Melanoma: Case 2
The Therapeutic Approach for Malignant Melanoma
Advertisement
April 2017
- A 52-year-old female presented to her dermatologist with a pigmented lesion which had recently become darker; she had it removed for cosmetic reasons
- Pathology revealed a melanoma with a depth of 2.3 mm
- Genetic testing;BRAF V600mutation-positive
- LDH, WNL (174 UI/L)
- She underwent wide local excision and sentinel node mapping; staining is positive for melanoma in the right axillary node
- Complete dissection of the right axilla reveals no additional involved nodes
- CT of the chest, abdomen, and pelvis showed multiple masses in both lungs, the largest being 5 mm
- She underwent core-needle biopsy of the largest lung lesion
- Pathology revealed metastatic melanoma
- Mutation testing:BRAF-positive
- The patient is started on dabrafenib 150 mg bid and trametinib 2 mg qd
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts NDA for Daraxonrasib in Metastatic Pancreatic Cancer
2
Advanced Renal Cell Carcinoma: Tailoring Second-Line Therapy After Prior Immunotherapy
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Teclistamab/Talquetamab Reduces Risk of Progression by 89% in R/R Multiple Myeloma
5





























